/

Batteries & E-Mobility

/

Athenex

Athenex

Athenex

Verified Nov 2026

Batteries & E-Mobility

·

United States flag

Buffalo, New York

·

Since 2003

Athenex is a biopharmaceutical company headquartered in Buffalo, New York, founded in 2003 and employing 50 to 100 people. It develops cancer therapies across three platforms: an oncology innovation unit for next-generation treatments, a commercial manufacturing and distribution operation, and a global supply chain division. The company serves the automotive, electric-vehicle, and medical industries through oral chemotherapy enhancements, topical treatments, and advanced cell therapies.

Athenex

Verified Nov 2026

AT A GLANCE

Founded

2003

Headquarters

United States flag

Buffalo, New York

Employees

50-100

Ownership

Athenex at a glance

Revenue

$100-250M

Est. band

Employees

50-100

Founded

2003

Headquarters

Buffalo, New York

Industries

Automotive

Electric Vehicles

Medical

Overview

Athenex is a biopharmaceutical company headquartered in Buffalo, New York, founded in 2003 and employing 50 to 100 people. It develops cancer therapies across three platforms: an oncology innovation unit for next-generation treatments, a commercial manufacturing and distribution operation, and a global supply chain division. The company serves the automotive, electric-vehicle, and medical industries through oral chemotherapy enhancements, topical treatments, and advanced cell therapies.

At a glance

Attribute

Detail

Founded

2003

Headquarters

Buffalo, New York

Employees

50-100

Revenue

$100-250M (estimated)

Primary capability

Batteries & E-Mobility

What Athenex makes

The company operates manufacturing and distribution capabilities across North America, China, and Asia, with a facility in Dunkirk, New York.

Latest developments

Facilities

Athenex is headquartered in Buffalo, New York. Public sources also reference these locations:

Company details

Athenex is a privately held firm with estimated annual revenue between $100 million and $250 million, collaborating with pharmaceutical companies, universities, and healthcare providers on oncology product development. Athenex was founded in 2003, has an estimated 50-100 employees, and is headquartered in Buffalo, New York.

Frequently asked questions

What does Athenex make?

Athenex is a biopharmaceutical company headquartered in Buffalo, New York, founded in 2003 and employing 50 to 100 people. It develops cancer therapies across three platforms: an oncology innovation unit for next-generation treatments, a commercial manufacturing and distribution operation, and a global supply chain division. The company serves the automotive, electric-vehicle, and medical industries through oral chemotherapy enhancements, topical treatments, and advanced cell therapies.

Where is Athenex headquartered?

Athenex is headquartered in Buffalo, New York (1001 Main Street, Buffalo, New York, 14203).

When was Athenex founded?

Athenex was founded in 2003.

How big is Athenex?

Athenex has an estimated 50-100 employees, with revenue in the $100-250M range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Buffalo, New York (HQ)Headquarters · United States
Buffalo, New York (HQ)1001 Main Street, Buffalo, New York, 14203, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.